X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

First batch of COVID-19 vaccines may arrive in Poland next month: deputy health minister

20.11.2020 07:00
A first batch of newly developed COVID-19 vaccines may arrive in Poland as early as next month, a deputy health minister has said, amid optimistic progress reports from several international drug makers.
Polish Deputy Health Minister Waldemar Kraska.
Polish Deputy Health Minister Waldemar Kraska.PR24/AK

Waldemar Kraska told public broadcaster Polish Radio that several new vaccines were expected to hit the Polish market in the first quarter of 2021, with the first supplies likely to reach the country in December.

He noted that a number of international pharmaceutical companies were finishing work on their own vaccines against COVID-19.

In the near future, these new vaccines are expected to be cleared for general use by global and European drug regulators, Kraska said.

After making sure these products are safe, the government will try to persuade as many Poles as possible to vaccinate themselves against COVID-19, he added.

Kraska also told Polish Radio that a special team was at work at his ministry to map out the logistics of a nationwide COVID-19 vaccination campaign.

A vaccination plan is due to be ready by mid-December, he said this week.

Poland’s prime minister said last week that millions of vaccines against the coronavirus were likely to reach his country next spring as part of a European deal with drug makers.

The European Union in the middle of last week struck a deal to buy up to 300 million doses of a potential coronavirus vaccine from US pharmaceutical firm Pfizer and its German partner BioNTech.

Prime Minister Mateusz Morawiecki said last Friday that his government has set up a working group with experts from Pfizer amid efforts to make a COVID-19 vaccine available to Poles as quickly as possible.

At the end of last week, Morawiecki also talked with executives from global pharmaceutical company AstraZeneca as part of efforts to secure a COVID-19 vaccine for Poland, state news agency PAP has reported.

Meanwhile, US drug maker Moderna announced on Monday that its experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage trial.

The European Commission on Tuesday authorized a deal with German biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine for European citizens.

EU officials have voiced hope for a deal with Moderna soon.

Data published on Thursday showed that AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, with researchers expecting to release late-stage trial results by Christmas, the Reuters news agency reported.

(gs/pk)

Source: IAR, Reuters